Cytokine Production and Monocyte HLA-DR Expression as Predictors of Outcome for Patients with Community-Acquired Severe Infections

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 1, 2004, Pages 161-167

  Lekkou, A ^a   Karakantza, M ^a   Mouzaki, A ^a   Kalfarentzos, F ^a   Gogos, C A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; COMMUNICABLE DISEASE; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; HYPOXEMIA; IMMUNE STATUS; KIDNEY FAILURE; MALE; MONOCYTE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; COMMUNITY-ACQUIRED INFECTIONS; CYTOKINES; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; MONOCYTES; PROGNOSIS; SEPSIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0347128297     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.1.161-167.2004     Document Type: Article

References (34)

1. American College of Chest Physicians/Society of Critical Medicine Consensus Committee. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit. Care Med. 20:864-874.
2. Auriant, I., I. Vinatier, F. Thaler, M. Tourneur, and P. Loirat. 1998. Simplified acute physiology score 11 for measuring severity of illness in the intermediate care units. Crit. Care Med. 26:1368-1371.
3. Balk, R. A. 2000. Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit. Care Clin. 16:337-352.
4. Blackwell, T. S., and J. W. Christman. 1996. Sepsis and cytokines: current status. Br. J. Anaesth. 77:110-117.
5. Casey, L. C., R. A. Balk, and R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-778.
6. Cheadle, W. G. 1993. The human leukocyte antigens and their relationship to infection. Am. J. Surg. 165:S75-S81.
7. Czarniecki, C. W., H. H. Chiu, G. H. Wong, S. M. McCabe, and M. A. Palladino. 1988. Transforming growth factor-beta 1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140:4217-4223.
8. Damas, P., J. L. Canivet, D. de Groote, Y. Vrindts, A. Albert, P. Franchimont, and M. Lamy. 1997. Sepsis and serum cytokine concentrations. Crit. Care Med. 25:405-412.
9. Ditschkowski, M., E. Kreuzfelder, V. Rebmann, S. Ferencik, M. Majetschak, E. N. Schmid, U. Obertacke, H. Hirche, U. F. Schade, and H. Grosse-Wilde. 1999. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann. Surg. 229:246-254.
10. Döcke, W. D., F. Randow, U. Syrbe, D. Krausch, K. Asadullah, P. Reinke, H. D. Volk, and W. Kox. 1997. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3:678-681.
11. Fumeaux, T., and J. Pugin. 2002. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am. J. Respir. Crit. Care Med. 166:1475-1482.
12. Gogos, C. A., E. Drosou, H. P. Bassaris, and A. Skoutelis. 2000. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J. Infect. Dis. 181:176-180.
13. Haveman, J. W., A. C. Muller Kobold, J. W. Cohen Tervaert, A. P. van den Berg, J. E. Tulleken, C. G. M. Kallenberg, and T. H. The. 1999. The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth. J. Med. 55:132-141.
14. Hershman, M. J., W. G. Cheadle, S. R. Wellhausen, P. F. Davidson, and H. C. Polk, Jr. 1990. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br. J. Surg. 77:204-207.
15. Koppelman, B., J. J. Neerjes, J. E. de Vries, and R. de Waal Malefyt. 1997. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. Immunity 7:861-871.
16. Lin, R. Y., M. E. Astiz, J. C. Saxon, D. C. Saha, and E. C. Rackow. 1994. Relationships between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit. Care Med. 22:1595-1602.
17. Manjuck, J., D. C. Saha, M. Astiz, L.-J. Eales, and E. C. Rackow. 2000. Decreased response to recall antigens is associated with depressed costimulatory receptor expression in septic critically ill patients. J. Lab. Clin. Med. 135:153-160.
18. Marchant, A., J. Deviere, B. Byl, D. de Groote, J. L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343:707-708.
19. Marie, C., and M.-R. Losser. 1996. Elevated levels of circulating transforming growth factor-β1 in patients with the sepsis syndrome. Ann. Intern. Med. 125:520-521.
20. Morel, A. S., G. Coulton, and M. Londei. 2002. Regulation of major histocompatibility complex class II synthesis by interleukin-10. Immunology 106:229-236.
21. Nandan, D., and N. E. Reiner. 1997. TGF-beta attenuates the class II transactivator and reveals an accessory pathway of IFN-gamma action. J. Immunol. 158:1095-1101.
22. Parrillo, J. E., M. M. Parker, C. Natanson, A. F. Suffredini, R. L. Danner, R. E. Cunnion, and F. P. Ognibene. 1990. Septic shock in humans, advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann. Intern. Med. 113:227-240.
23. Perrella, M. A., C.-M. Hsieh, W.-S. Lee, S. Shieh, J.-C. Tsai, C. Patterson, C. Lowenstein, N. C. Long, E. Haber, S. Shore, and M.-E. Lee. 1996. Arrest of endotoxin-induced hypotension by transforming growth factor β1. Proc. Natl. Acad. Sci. USA 93:2054-2059.
24. Pinsky, M. R. 2001. Sepsis: a pro- and anti-inflammatory disequilibrium syndrome. Contrib. Nephrol. 132:354-366.
25. Rangel-Frausto, M. S., D. Pitter, M. Costigan, T. Hwang, C. S. Davis, and R. P. Wenzel. 1995. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 11:117-123.
26. Sachse, C., M. Prigge, G. Cramer, N. Pallua, and E. Henkel. 1999. Association between reduced human leukocyte antigen (HLA)-DR expression on blood monocytes and increased plasma level of interleukin-10 in patients with severe burns. Clin. Chem. Lab. Med. 37:193-198.
27. Sfeir, T., D. C. Saha, M. Astiz, and E. C. Rackow. 2001. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit. Care Med. 29:129-133.
28. Sibbald, W. J., and J. L. Vincent. 1995. Round table conference on clinical trials for the treatment of sepsis. Crit. Care Med. 23:394-399.
29. Spittler, A., M. Razenberger, H. Kupper, M. Kaul, W. Hackl, G. Boltz-Nitulescu, R. Függer, and E. Roth. 2000. Relationship between interleukin-6 plasma concentration in patients with sepsis, monocyte phenotype, monocyte phagocytic properties, and cytokine production. Clin. Infect. Dis. 31:1338-1342.
30. van den Berk, J. M. M., R. H. J. Oldenburger, A. P. van den Berg, I. J. Klompmaker, G. Mesander, W. J. van Son, W. van der Bij, M. J. H. Slooff, and T. H. The. 1997. Low HLA-DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. Transplantation 63:1846-1848.
31. van der Poll, T., and S. J. H. van Deventer. 1999. Cytokines and anticytokines in the pathogenesis of sepsis. Infect. Dis. Clin. N. Am. 13:413-426.
32. van der Poll, T., R. de Waal Malefyt, S. M. Coyle, and S. F. Lowry. 1997. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin-1 receptor type II, IL-10 and IL-13. J. Infect. Dis. 175:118-122.
33. van Dissel, J. T., P. van Langevelde, R. G. J. Westendorp, K. Kwappenberg, and M. Frolich. 1998. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351:950-953.
34. Wakefield, C. H., P. D. Carey, S. Foulds, J. R. T. Monson, and P. J. Guillou. 1993. Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. Br. J. Surg. 80:205-209.